Literature DB >> 1080125

Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia.

W M Lee, W D Reed, C G Mitchell, I L Woolf, I W Dymock, A L Eddleston, R Williams.   

Abstract

Cellular immunity to the hepatitis B surface antigen (HBsAg) and a liver-specific lipoprotein was studied, using the leucocyte migration test, in 38 asymptomatic blood donors found to have HBsAg in the serum. Sensitization to HBsAg was found in 26% and was related to the presence of liver damage, being detected in 47% of those with elevated serum aspartate aminotransferase but in only 13% with normal enzyme levels. The frequency of sensitization to this antigen in those with chronic persistent or chronic aggressive hepatitis on biopsy was also higher than in those with unrelated or minimal changes. The findings using the liver-specific lipoprotein as antigen were similar and there was a correlation between the results obtained with this and the hapatitis B surface antigen. This study supports the hypothesis that a T-lymphocyte response to hepatitis B virus antigen can initiate an autoimmune reaction to antigens such as liver-specific lipoprotein on the hepatocyte surface, and that this reaction may be of importance in the production of chronic liver damage. In the absence of the T-cell response, the autoimmune reaction cannot occur and the virus is able to establish a harmless symbiotic union with the host.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080125      PMCID: PMC1411035          DOI: 10.1136/gut.16.6.416

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.

Authors:  W M Lee; W D Reed; C G Mitchell; R M Galbraith; A L Eddleston; A J Zuckerman; R Williams
Journal:  Br Med J       Date:  1975-03-29

2.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

3.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

4.  Exposure and immunity to hepatitis-B virus in a liver unit.

Authors:  W D Reed; C G Mitchell; A L Eddleston; W M Lee; R Williams; A J Zuckerman
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

5.  Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen.

Authors:  V Giustino; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

6.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

7.  Lymphocyte transformation by Australia antigen.

Authors:  A A Laiwah
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

8.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

9.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

10.  Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile.

Authors:  A L Eddleston; I G McFarlane; C G Mitchell; W D Reed; R Williams
Journal:  Br Med J       Date:  1973-11-03
View more
  9 in total

1.  Editorial: After type B hepatitis.

Authors: 
Journal:  Br Med J       Date:  1975-11-08

Review 2.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.

Authors:  M L Tiku; K R Beutner; P L Ogra
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

4.  Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.

Authors:  K R Beutner; M L Tiku; P L Ogra
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

5.  Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.

Authors:  R M Galbraith; N el Sheikh; B Portmann; A L Eddleston; R Williams; V Parsons; M Bewick; C S Ogg
Journal:  Br Med J       Date:  1976-06-19

6.  Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.

Authors:  B Hafkin; R B Pollard; M L Tiku; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods.

Authors:  B Portmann; R M Galbraith; A L Eddleston; A J Zuckerman; R Williams
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

8.  Cell-mediated immunity to hepatitis B surface antigen in man.

Authors:  R G Hanson; J H Hoofnagle; G Y Minuk; R H Purcell; J L Gerin
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

Authors:  C Ferrari; A Penna; P Sansoni; T Giuberti; T M Neri; F V Chisari; F Fiaccadori
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.